Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy.
Artem ChabanBirgit WaschulzikDenise BernhardtClaire DelbridgeFriederike Schmidt-GrafArthur WagnerBenedikt WiestlerWolfgang WeberIgor YakushevPublished in: European journal of nuclear medicine and molecular imaging (2024)
For monitoring of patients with rHGG under bevacizumab therapy, AA-PET should be preferred over RANO MRI.